• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿片类药物危机:加拿大安大略省过去、现在和未来的政策环境。

The opioid crisis: past, present and future policy climate in Ontario, Canada.

机构信息

Laurentian University, Sudbury, ON, Canada.

Northern Ontario School of Medicine, Sudbury, ON, P3E 2C6, Canada.

出版信息

Subst Abuse Treat Prev Policy. 2017 Nov 2;12(1):45. doi: 10.1186/s13011-017-0130-5.

DOI:10.1186/s13011-017-0130-5
PMID:29096653
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5667516/
Abstract

BACKGROUND

Addressing opioid use disorder has become a priority in Ontario, Canada, because of its high economic, social and health burden. There continues to be stigma and criticism relating to opioid use disorder and treatment options. The result has been unsystematic, partial, reactive policies and programs developed based on divergent points of view. The aim of this manuscript is to describe how past and present understandings, narratives, ideologies and discourse of opioid use, have impacted policies over the course of the growing opioid crisis.

COMMENTARY

Assessing the impact of policy is complex. It involves consideration of conceptual issues of what impacts policy change. In this manuscript we argue that the development of polices and initiatives regarding opioids, opioid use disorder and opioid agonist treatment in the last decade, have been more strongly associated with the evolution of ideas, narratives and discourses rather than research relating to opioids. We formulate our argument using a framework by Sumner, Crichton, Theobald, Zulu, and Parkhurs. We use examples from the Canadian context to outline our argument such as: the anti- drug legislation from the Canadian Federal Conservative government in 2007; the removal of OxyContin™ from the drug formulary in 2012; the rapid expansion of opioid agonist treatment beginning in the early 2000s, the unilateral decision made regarding fee cuts for physicians providing opioid agonist treatment in 2015; and the most recent implementation of a narcotics monitoring system, which are all closely linked with the shifts in public opinion and discourse at the time of which these policies and programs are implemented.

CONCLUSION

We conclude with recommendations to consider a multifactorial response using evidence and stakeholder engagement to address the opioid crisis, rather than a reactive policy approach. We suggest that researchers have an important role in shaping future policy by reframing ideas through knowledge translation, formation of values, creation of new knowledge and adding to the quality of public discourse and debate.

摘要

背景

由于阿片类药物使用障碍给加拿大安大略省带来了高昂的经济、社会和健康负担,因此解决这一问题已成为当务之急。针对阿片类药物使用障碍和治疗选择,人们的看法仍存在污名化和批评。结果是基于不同观点制定了非系统性、片面的、被动的政策和方案。本文旨在描述过去和现在对阿片类药物使用的理解、叙述、意识形态和话语如何影响不断发展的阿片类药物危机期间的政策。

述评

评估政策的影响很复杂。它涉及到考虑影响政策变化的概念问题。在本文中,我们认为,在过去十年中,关于阿片类药物、阿片类药物使用障碍和阿片类激动剂治疗的政策和倡议的制定,更多地与思想、叙述和话语的演变相关,而不是与阿片类药物相关的研究。我们使用 Sumner、Crichton、Theobald、Zulu 和 Parkhurs 的框架来提出我们的观点。我们使用加拿大的例子来阐述我们的观点,例如:2007 年加拿大联邦保守党政府的反毒品立法;2012 年将奥施康定从药物处方中删除;2000 年代初开始迅速扩大阿片类激动剂治疗,2015 年单方面决定削减为提供阿片类激动剂治疗的医生的费用;以及最近实施的麻醉品监测系统,这些都与当时的公众舆论和话语转变密切相关政策和计划的实施。

结论

我们的结论是,建议考虑采用多因素应对措施,利用证据和利益相关者的参与来解决阿片类药物危机,而不是采取被动的政策方法。我们建议研究人员通过知识转化、价值观形成、新知识创造以及为公共话语和辩论增添质量,在塑造未来政策方面发挥重要作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02bc/5667516/846ceadeb194/13011_2017_130_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02bc/5667516/846ceadeb194/13011_2017_130_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02bc/5667516/846ceadeb194/13011_2017_130_Fig1_HTML.jpg

相似文献

1
The opioid crisis: past, present and future policy climate in Ontario, Canada.阿片类药物危机:加拿大安大略省过去、现在和未来的政策环境。
Subst Abuse Treat Prev Policy. 2017 Nov 2;12(1):45. doi: 10.1186/s13011-017-0130-5.
2
Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.超越黑木树:影响澳大利亚地区、农村和偏远地区的健康研究问题的快速综述。
Med J Aust. 2020 Dec;213 Suppl 11:S3-S32.e1. doi: 10.5694/mja2.50881.
3
Losing the uphill battle? Emergent harm reduction interventions and barriers during the opioid overdose crisis in Canada.在加拿大阿片类药物过量危机期间,错失这场艰难斗争的胜利?紧急减少危害干预措施和障碍。
Int J Drug Policy. 2019 Sep;71:178-182. doi: 10.1016/j.drugpo.2019.02.005. Epub 2019 Apr 8.
4
At-a-glance - What can social media tell us about the opioid crisis in Canada?一眼看尽 - 社交媒体能告诉我们加拿大的阿片类药物危机有哪些情况?
Health Promot Chronic Dis Prev Can. 2018 Jun;38(6):263-267. doi: 10.24095/hpcdp.38.6.08.
5
"Like being put on an ice floe and shoved away": A qualitative study of the impacts of opioid-related policy changes on people who take opioids.“就像被放在浮冰上然后被推开”:一项定性研究,探讨阿片类药物相关政策变化对使用阿片类药物者的影响。
Int J Drug Policy. 2019 Apr;66:15-22. doi: 10.1016/j.drugpo.2019.01.015. Epub 2019 Jan 24.
6
The ever-changing narrative: Supervised injection site policy making in Ontario, Canada.不断变化的叙述:加拿大安大略省监督注射点政策制定。
Int J Drug Policy. 2019 Dec;74:98-111. doi: 10.1016/j.drugpo.2019.09.006. Epub 2019 Oct 3.
7
Institutional Engagement Practices as Barriers to Public Health Capacity in Climate Change Policy Discourse: Lessons from the Canadian Province of Ontario.机构参与实践对气候变化政策话语中公共卫生能力建设的阻碍:来自加拿大安大略省的经验教训。
Int J Environ Res Public Health. 2020 Aug 31;17(17):6338. doi: 10.3390/ijerph17176338.
8
Systematic Evaluation of State Policy Interventions Targeting the US Opioid Epidemic, 2007-2018.系统评价针对美国阿片类药物流行的国家政策干预措施,2007-2018 年。
JAMA Netw Open. 2021 Feb 1;4(2):e2036687. doi: 10.1001/jamanetworkopen.2020.36687.
9
Opioid agonist treatment (OAT) experiences and release plans among federally incarcerated individuals with opioid use disorder (OUD) in Ontario, Canada: a mixed-methods study.加拿大安大略省患有阿片类药物使用障碍(OUD)的联邦监狱服刑人员的阿片类激动剂治疗(OAT)经历与释放计划:一项混合方法研究
BMC Public Health. 2022 Mar 4;22(1):436. doi: 10.1186/s12889-022-12685-0.
10
Rationale for cannabis-based interventions in the opioid overdose crisis.在阿片类药物过量危机中使用大麻类药物干预的理由。
Harm Reduct J. 2017 Aug 18;14(1):58. doi: 10.1186/s12954-017-0183-9.

引用本文的文献

1
Opioid analgesics for chronic noncancer pain in patients prescribed opioid agonist therapy or with opioid use disorder: A systematic review.用于接受阿片类激动剂治疗或患有阿片类药物使用障碍患者的慢性非癌性疼痛的阿片类镇痛药:一项系统评价。
Can J Pain. 2025 Jul 31;9(1):2499553. doi: 10.1080/24740527.2025.2499553. eCollection 2025.
2
The effects of a provincial opioid prescribing standard on prescribing for pain in adults: an interrupted time-series analysis.一项省级阿片类药物处方标准对成人疼痛处方的影响:中断时间序列分析。
CMAJ. 2025 May 11;197(18):E497-E505. doi: 10.1503/cmaj.250167.
3
Co-Designing a Digital Brief Intervention to Reduce the Risk of Prescription Opioid-Related Harm Among People With Chronic Noncancer Pain: Qualitative Analysis of Patient Lived Experiences.

本文引用的文献

1
Prescription opioid prescribing, use/misuse, harms and treatment among Aboriginal people in Canada: a narrative review of available data and indicators.加拿大原住民中处方阿片类药物的开具、使用/滥用、危害及治疗:现有数据与指标的叙述性综述
Rural Remote Health. 2016 Oct-Dec;16(4):3974. Epub 2016 Nov 22.
2
Too much or never enough: a response to Treatment of opioid disorders in Canada: looking at the 'other epidemic'.要么过量,要么永远不够:对《加拿大阿片类药物障碍的治疗:审视“另一场流行病”》的回应。
Subst Abuse Treat Prev Policy. 2016 Sep 20;11(1):33. doi: 10.1186/s13011-016-0076-z.
3
Treatment of prescription opioid disorders in Canada: looking at the 'other epidemic'?
共同设计数字简短干预措施以降低慢性非癌性疼痛患者处方阿片类药物相关伤害风险:患者生活经历的定性分析
JMIR Form Res. 2025 Jan 30;9:e57208. doi: 10.2196/57208.
4
Do we need urine drug screens in opioid addiction treatment: An observational study on self-report versus urine drug screens.在阿片类药物成瘾治疗中我们需要进行尿液药物筛查吗:一项关于自我报告与尿液药物筛查的观察性研究
Addict Behav Rep. 2024 Nov 27;21:100575. doi: 10.1016/j.abrep.2024.100575. eCollection 2025 Jun.
5
An Indigenous-led buprenorphine-naloxone treatment program to address opioid use in remote Northern Canada.一项由原住民主导的丁丙诺啡-纳洛酮治疗项目,旨在解决加拿大北部偏远地区的阿片类药物使用问题。
Dialogues Health. 2024 Sep 1;5:100190. doi: 10.1016/j.dialog.2024.100190. eCollection 2024 Dec.
6
Assessing support for substance use policies among the general public and policy influencers in two Canadian provinces.评估加拿大两个省份的普通公众和政策影响者对药物使用政策的支持情况。
Subst Abuse Treat Prev Policy. 2024 Sep 4;19(1):40. doi: 10.1186/s13011-024-00622-w.
7
Opioid-related deaths in Northern Ontario in the early COVID-19 pandemic period.安大略省北部在新冠疫情早期与阿片类药物相关的死亡情况。
Can J Public Health. 2024 Jul 29. doi: 10.17269/s41997-024-00906-5.
8
Spatiotemporal epidemiology of substance-related accidental acute toxicity deaths in Canada from 2016 to 2017.2016 年至 2017 年加拿大与物质相关的意外急性毒性死亡的时空流行病学。
BMC Public Health. 2024 Jun 20;24(1):1641. doi: 10.1186/s12889-024-18883-2.
9
A genome-wide association, polygenic risk score and sex study on opioid use disorder treatment outcomes.全基因组关联、多基因风险评分和性别对阿片类药物使用障碍治疗结果的研究。
Sci Rep. 2023 Dec 15;13(1):22360. doi: 10.1038/s41598-023-49605-0.
10
Evidence of Increased Age and Sex Standardized Death Rates Among Individuals Who Accessed Opioid Agonist Treatment Before the Era of Synthetic Opioids in Ontario, Canada.在加拿大安大略省合成阿片类药物时代之前接受阿片类激动剂治疗的个体中,年龄和性别标准化死亡率上升的证据。
Cureus. 2021 Oct 26;13(10):e19051. doi: 10.7759/cureus.19051. eCollection 2021 Oct.
加拿大处方阿片类药物障碍的治疗:关注“另一场流行病”?
Subst Abuse Treat Prev Policy. 2016 Mar 8;11:12. doi: 10.1186/s13011-016-0055-4.
4
Evaluating the Effectiveness of First-Time Methadone Maintenance Therapy Across Northern, Rural, and Urban Regions of Ontario, Canada.评估加拿大安大略省北部、农村和城市地区首次美沙酮维持治疗的效果。
J Addict Med. 2015 Nov-Dec;9(6):440-6. doi: 10.1097/ADM.0000000000000156.
5
Evaluation of an inpatient medical withdrawal program in rural Ontario: a 1-year prospective study.安大略省农村地区住院医疗戒毒项目评估:一项为期1年的前瞻性研究。
Can J Rural Med. 2015 Summer;20(3):92-7.
6
Tamper-resistant drugs cannot solve the opioid crisis.抗篡改药物无法解决阿片类药物危机。
CMAJ. 2015 Jul 14;187(10):717-718. doi: 10.1503/cmaj.150329. Epub 2015 Jun 29.
7
Opioid abuse in the United States and Department of Health and Human Services actions to address opioid-drug-related overdoses and deaths.美国的阿片类药物滥用情况以及美国卫生与公众服务部为应对与阿片类药物相关的过量用药和死亡所采取的行动。
J Pain Palliat Care Pharmacother. 2015 Jun;29(2):133-9. doi: 10.3109/15360288.2015.1037530.
8
Trends in opioid analgesic abuse and mortality in the United States.美国阿片类镇痛药滥用及死亡率趋势
N Engl J Med. 2015 Apr 16;372(16):1573-4. doi: 10.1056/NEJMc1501822.
9
Trends in opioid analgesic abuse and mortality in the United States.美国阿片类镇痛药滥用和死亡率的趋势。
N Engl J Med. 2015 Jan 15;372(3):241-8. doi: 10.1056/NEJMsa1406143.
10
The burden of premature opioid-related mortality.过早出现的与阿片类药物相关的死亡负担。
Addiction. 2014 Sep;109(9):1482-8. doi: 10.1111/add.12598. Epub 2014 Jul 7.